253 related articles for article (PubMed ID: 31039332)
21. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
Emerson MV; Lauer AK
BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
[TBL] [Abstract][Full Text] [Related]
22. VEGF inhibitors for AMD and diabetic macular edema.
Med Lett Drugs Ther; 2015 Mar; 57(1464):41-2. PubMed ID: 25758545
[No Abstract] [Full Text] [Related]
23. [Anti-VEGF therapy resistance in neovascular age-related macular degeneration].
Budzinskaya MV; Plyukhova AA; Sorokin PA
Vestn Oftalmol; 2017; 133(4):103-108. PubMed ID: 28980574
[TBL] [Abstract][Full Text] [Related]
24. IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration.
Doyle SL; Ozaki E; Brennan K; Humphries MM; Mulfaul K; Keaney J; Kenna PF; Maminishkis A; Kiang AS; Saunders SP; Hams E; Lavelle EC; Gardiner C; Fallon PG; Adamson P; Humphries P; Campbell M
Sci Transl Med; 2014 Apr; 6(230):230ra44. PubMed ID: 24695684
[TBL] [Abstract][Full Text] [Related]
25. Treatment of retinal diseases with VEGF antagonists.
Schlingemann RO; Witmer AN
Prog Brain Res; 2009; 175():253-67. PubMed ID: 19660661
[TBL] [Abstract][Full Text] [Related]
26. Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration.
Barouch FC; Miller JW
Int Ophthalmol Clin; 2004; 44(3):23-32. PubMed ID: 15211174
[No Abstract] [Full Text] [Related]
27. A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.
Toledano S; Lu H; Palacio A; Ziv K; Kessler O; Schaal S; Neufeld G; Barak Y
PLoS One; 2016; 11(12):e0168122. PubMed ID: 28036336
[TBL] [Abstract][Full Text] [Related]
28. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
29. Rice Bran and Vitamin B6 Suppress Pathological Neovascularization in a Murine Model of Age-Related Macular Degeneration as Novel HIF Inhibitors.
Ibuki M; Lee D; Shinojima A; Miwa Y; Tsubota K; Kurihara T
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255657
[TBL] [Abstract][Full Text] [Related]
30. Current advances in the treatment of neovascular age-related macular degeneration.
Villegas VM; Aranguren LA; Kovach JL; Schwartz SG; Flynn HW
Expert Opin Drug Deliv; 2017 Feb; 14(2):273-282. PubMed ID: 27434329
[TBL] [Abstract][Full Text] [Related]
31. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG
Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161
[TBL] [Abstract][Full Text] [Related]
32. Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.
Santonocito M; Zappulla C; Viola S; La Rosa LR; Solfato E; Abbate I; Tarallo V; Apicella I; Platania CBM; Maugeri G; D'Agata V; Bucolo C; De Falco S; Mazzone MG; Giuliano F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922399
[TBL] [Abstract][Full Text] [Related]
33. Targeted pharmacotherapy of retinal diseases with ranibizumab.
Campochiaro PA
Drugs Today (Barc); 2007 Aug; 43(8):529-37. PubMed ID: 17925884
[TBL] [Abstract][Full Text] [Related]
34. Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment.
Zhang X; Bohner A; Bhuvanagiri S; Uehara H; Upadhyay AK; Emerson LL; Bondalapati S; Muddana SK; Fang D; Li M; Sandhu Z; Hussain A; Carroll LS; Tiem M; Archer B; Kompella U; Patil R; Ambati BK
Mol Ther; 2017 Jul; 25(7):1606-1615. PubMed ID: 28236576
[TBL] [Abstract][Full Text] [Related]
35. The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration.
Teo KYC; Gillies M; Fraser-Bell S
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30177632
[TBL] [Abstract][Full Text] [Related]
36. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
37. Metabolic physiology in age related macular degeneration.
Stefánsson E; Geirsdóttir A; Sigurdsson H
Prog Retin Eye Res; 2011 Jan; 30(1):72-80. PubMed ID: 20951826
[TBL] [Abstract][Full Text] [Related]
38. Assessment of anterior chamber inflammation after intravitreal bevacizumab injection in different ocular exudative diseases.
Yeniad B; Ayranci O; Tuncer S; Kir N; Ovali T; Tugal-Tutkun I; Akarcay K
Eur J Ophthalmol; 2011; 21(2):156-61. PubMed ID: 20658459
[TBL] [Abstract][Full Text] [Related]
39. ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.
Gong Y; Fu Z; Liegl R; Chen J; Hellström A; Smith LE
Am J Clin Nutr; 2017 Jul; 106(1):16-26. PubMed ID: 28515072
[TBL] [Abstract][Full Text] [Related]
40. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
Nguyen QD; De Falco S; Behar-Cohen F; Lam WC; Li X; Reichhart N; Ricci F; Pluim J; Li WW
Acta Ophthalmol; 2018 Feb; 96(1):e1-e9. PubMed ID: 27874278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
